ZIVO

Zivo Bioscience, Inc.

OTC · Biological Products, (No Diagnostic Substances) · Inc. NV · CIK 0001101026
$3.05 0.00%
Insider Buying Cluster (2 insiders)
Vol
Insider Activity5B / 0S
Insider Net $$435.4K
Exchange OTC·Sector Biological Products, (No Diagnostic Substances)·Inc. NV·CIK 0001101026·Prev Close $3.05

Recent Activity

May 13, 2026 earnings_calendar
ZIVO Q1 2026 Earnings Scheduled — 2026-05-13
Apr 17, 2026 Insider
STROME MARK E bought 100,000 shares
10%+ Owner @ $2.00 ($200.0K)
Feb 27, 2026 Insider
YALDOO LAITH L bought 1,543 shares
Director @ $9.72 ($15.0K)
Feb 12, 2026 Insider
STROME MARK E bought 20,000 shares
10%+ Owner @ $9.77 ($195.4K)

Analyst Ratings

Historical distribution0% buy · 6 analysts · last covering-analyst action Jun 2024
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jun 4, 2024 Maxim Group DOWNGRADE Buy → Hold

Recent Insider Trades

DateInsiderTypeValue
Apr 17, 2026STROME MARKBUY$200.0K
Feb 27, 2026YALDOO LAITHBUY$15.0K
Feb 12, 2026STROME MARKBUY$195.4K
Feb 12, 2026STROME MARKBUY$0.00
Feb 10, 2026YALDOO LAITHBUY$25.0K

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

2 unique insiders with 5 transactions. Net insider value: $435.4K ($435.4K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Apr 17, 2026STROME MARK E10%+ OwnerBUY100,000$2.00$200.0K
Feb 27, 2026YALDOO LAITH LDirectorBUY1,543$9.72$15.0K
Feb 12, 2026STROME MARK E10%+ OwnerBUY20,000$9.77$195.4K
Feb 12, 2026STROME MARK E10%+ OwnerBUY2,000$0.00$0.00
Feb 10, 2026YALDOO LAITH LDirectorBUY2,434$10.27$25.0K

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jun 2024): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jun 4, 2024 Maxim Group DOWNGRADE Buy Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 2026003120%
May 1, 2026003120%
Apr 1, 2026003120%
Mar 1, 2026003120%
Feb 1, 2026003120%
Jan 1, 2026003120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
ZIVO Q1 2026 Earnings Scheduled — 2026-05-13
Apr 27, 2026
earnings_calendar
ZIVO Q4 2025 Earnings Scheduled — 2026-04-27
Apr 17, 2026
earnings_calendar
ZIVO Q4 2025 Earnings Scheduled — 2026-04-17
Apr 15, 2026
earnings_calendar
ZIVO Q4 2025 Earnings Scheduled — 2026-04-15
Apr 6, 2026
earnings_calendar
ZIVO Q4 2025 Earnings Scheduled — 2026-04-06
Mar 16, 2026
earnings_calendar
ZIVO Q4 2025 Earnings Scheduled — 2026-03-16